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Abstract
Background: Human S100A12 is a member of the S100 family of EF-hand calcium-modulated proteins
that are associated with many diseases including cancer, chronic inflammation and neurological disorders.
S100A12 is an important factor in host/parasite defenses and in the inflammatory response. Like several
other S100 proteins, it binds zinc and copper in addition to calcium. Mechanisms of zinc regulation have
been proposed for a number of S100 proteins e.g. S100B, S100A2, S100A7, S100A8/9. The interaction of
S100 proteins with their targets is strongly dependent on cellular microenvironment.
Results: The aim of the study was to explore the factors that influence S100A12 oligomerization and
target interaction. A comprehensive series of biochemical and biophysical experiments indicated that
changes in the concentration of calcium and zinc led to changes in the oligomeric state of S100A12. Surface
plasmon resonance confirmed that the presence of both calcium and zinc is essential for the interaction
of S100A12 with one of its extracellular targets, RAGE – the Receptor for Advanced Glycation End
products. By using a single-molecule approach we have shown that the presence of zinc in tissue culture
medium favors both the oligomerization of exogenous S100A12 protein and its interaction with targets
on the cell surface.
Conclusion: We have shown that oligomerization and target recognition by S100A12 is regulated by both
zinc and calcium. Our present work highlighted the potential role of calcium-binding S100 proteins in zinc
metabolism and, in particular, the role of S100A12 in the cross talk between zinc and calcium in cell
signaling.
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Background
S100A12 and other proteins of this family have been
implicated in the regulation of a wide range of physiolog-
ical and pathophysiological processes [1-3].
Human S100A12 was discovered in blood cells [4]. It was
estimated that it constituted about 5% of total cytosolic
protein in resting neutrophils. Soon after this discovery
the first data on S100A12 functional activity were
reported. A calgranulin-related protein (CGRP) was puri-
fied from the extracts of the human parasite Onchocerca
volvulus [5]. A search for S100A12 binding sites on another
helminth, Brugia malayi, resulted in the identification of
paramyosin, a muscle protein localized just below the
parasite's cuticle [6]. A further search of S100A12 targets
led to the discovery of RAGE – the Receptor of Advanced
Glycation End products [7]. RAGE is a pattern recognition
receptor and a multiligand member of the immunoglob-
ulin superfamily of cell surface adhesion molecules [8,9].
RAGE is linked to cellular dysfunction in several inflam-
matory disorders, in tumors and in diabetes [10-12]. It
was proposed that the interaction of RAGE with S100A12
mediates proinflammatory effects on lymphocytes and
mononuclear phagocytes [7]. Existence of another recep-
tor, different from RAGE, was suggested in the recent
report on the effect of S100A12 and its "hinge" peptide on
mast cell and monocyte recruitement. Interactions with
an as yet unidentified G-protein coupled receptor were
proposed [13]. These and other data indicate that extracel-
lular S100A12 interactions with its diverse targets may
contribute to the pathogenesis of many diseases and
inflammatory responses [14-16] including some neurode-
generative disorders [17]. High-resolution structural data
of RAGE/S100 complex are still unavailable. However, a
significant impact on the mechanism of these interactions
has been made by X-ray crystallography of S100A12 pro-
tein [18,19] and NMR studies of RAGE/S100A12 complex
[20].
A few intracellular targets of S100A12 namely cytosolic
NADP+-dependent isocitrate dehydrogenase (IDH), fruc-
tose-1,6-bisphosphate aldolase A (aldolase), glyceralde-
hyde-3-phosphate dehydrogenese (GAPDH), annexin V
and S100A9 have also been detected [21]. The ability of
S100A12 for translocation to the cellular membrane and
its secretion [4,22] raises a question whether some of its
targets are able to form a complex with a transport func-
tion. These putative "S100 transporters" are still
unknown. However S100A13 multiprotein secreted com-
plex has recently been identified [23].
Several S100 proteins bind zinc. Two major types of zinc-
binding sites (with and without cysteine residues) have
been identified. The cysteine free Zn-binding site was fully
characterized from the 3D structure of S100A7 [24] and
S100B [25]. Different zinc-binding motifs containing
cysteine were suggested for S100A2 based on the NMR
data and homology modeling [26]. S100 proteins were
characterized by a wide range of zinc binding constant
(S100B [Kd 90 nM], S100A2 [Kd 25 nM], S100A3 [Kd 1.5
μM], S100A5 [Kd 2 μM], S100A6 [Kd 0.1 μM] and S100A7
[Kd 100 μM]), and in each case a conformational change
was observed upon binding of Zn2+ ions [24-30]. Zinc
binding constant for pig S100A12 was estimated from flu-
orescence titration curves (Kd < 10 nM), binding of zinc
caused a large increase (~1500-fold) in its affinity for Ca2+
[31]. An opposite effect has been shown for S100A2 pro-
tein. Recent findings suggest that Zn2+ might deactivate
S100A2 by inhibiting response to intracellular Ca2+ sig-
nals [32]. The role of Zn in S100 Ca binding proteins is so
far not clear. However, evidence of the influence of zinc
on the levels of the intracellular calcium started to emerge.
In particular, changes in the extracellular zinc concentra-
tions triggered a release of calcium from the intracellular
pools in colonocytic cell line HT29, so the presence of an
uncharacterized zinc-sensing receptor was proposed [33].
In another study, zinc inhibited calcium influx by block-
ing store-operated calcium channel (SOCC) in human
salivary gland cells suggesting redox-dependent regula-
tion [34]. Despite its clinical importance little is known
about cellular signaling mechanisms that sense changes in
extracellular zinc concentration. A missing link between
extracellular zinc and regulation of cellular physiological
processes might be an important cellular transduction
pathway in the cross talk between the cell and its microen-
vironment. Although the total zinc concentration in
serum is about 15 μM [35,36], almost all of that is bound
to the proteins, with a very wide range of zinc affinity from
picomolar to micromolar levels, which means that zinc is
exchangeable and this exchange depends on the local con-
centration of zinc binding proteins with different Zn2+
affinity.
Our present work draws attention to a potentially signifi-
cant role of S100 proteins in Zn metabolism. Zn binding
to S100A12 protein provides a greater diversity of protein
conformational changes and therefore may dramatically
modulate its function as a result of changes in the cellular
microenvironment.
Results
S100A12 binds to the cellular surface in a zinc dependent 
manner
The viability and growth of tissue cell culture cell lines
depend on the presence of metal ions in a cell culture
medium. Fluctuations of extracellular zinc appear to be a
significant aspect of cellular signal transduction. Several
well established tissue cell culture mediums contain
remarkably different concentrations of divalent cations
such as calcium, zinc and copper (see Methods). ThoughBMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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the experiments with cells exposed to Zn or Cu are some-
times difficult to interpret numerous data indicate a target
upstream of the intracellular signaling pathways.
We analyzed the binding of S100A12 to the cellular sur-
face of human gastric carcinoma MKN74 cells in RPMI-
1640 and F12 medium. This cell line expresses an elevated
level of endogenous RAGE [37]. To reduce the rate of
endocytosis the binding reaction was performed at 10°C
or at room temperature. We demonstrated that S100A12
could be detected on the cellular surface by using near
field scanning optical microscopy (NSOM). Remarkably
the S100A12 binding in F12 medium containing zinc
showed a different binding pattern compared to that of
zinc depleted RPMI-1640 medium (Fig. 1A, B). Morpho-
logically many bright speckles (0.6 clusters/square
micrometer) of fluorescence were detected on the cell sur-
face in the F12 zinc containing medium. In the RPMI-
1640 medium the number of fluorescent dots were mark-
edly decreased to less than 0.2 clusters/square microme-
ter. We suggest that incubation of MKN74 cells in the Zn
containing medium in the presence of exogeneous recom-
binant S100A12 led to the more efficient binding of
S100A12 to cell surface receptors or other molecules. (Fig.
1A, B). Although these results do not allow us to distin-
guish between the various dimeric, tetrameric and hexam-
eric structures suggested by X-ray analysis and other
analytical techniques, it is obvious that clustering and
assembly of S100A12 with extracellular receptors in the
presence of zinc are significantly enhanced. It is very likely
that oligomerisation occurs in the solution and oligomers
are then trapped on the cellular surface as large clusters in
the range of 100–400 nm. We can suggest that such
observed clustering is a combined result of S100A12 and
receptor aggregation. It was intriguing to speculate that
S100A12 cellular binding activity could be a property
associated with protein conformational changes mediated
by the action of both Ca and Zn ions.
These results were also confirmed by confocal fluorescent
microscopy (Fig. 1C, D, E). Both sets of data provide evi-
dence that the presence of Zn in cell culture medium is
important for S100A12 oligomerization and its binding
to cell surface molecules. Cellular assays at this stage of
NSOM topography and fluorescent images of MKN74 cells treated with S100A12 Figure 1
NSOM topography and fluorescent images of MKN74 cells treated with S100A12. in F12 (A) and RPMI 1640 (B) 
cell media. Major fraction of the clusters detected has an intensity of ~2 MHz (million counts per second). Fractions with inten-
sities ~4, 8, and 10 MHz were also detected suggesting the presence of S100 aggregates greater than hexamers. Total number 
of clusters detected was ~500/image. (C-E) Images of gastric carcinoma MKN74 cells captured by epifluorescence microscopy. 
Cells were incubated in the presence of S100A12 protein in RPMI (C), F12K (D) and F12 (E) cellular mediums without serum. 
Cells were stained with affinity-purified rabbit anti-S100A12.BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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research were postponed due to a very complicated inter-
pretation of S100A12 binding targets. It was shown that
different extracellular molecules such as heparin sulphate
proteoglycans were able to bind S100A12 and other S100
proteins [38]. RAGE receptor – the primary S100A12 tar-
get – is not uniformly glycosylated in vivo and only a small
proportion of RAGE molecules are able to form a produc-
tive complex with its ligands [39,40], (Srikrishna & Freeze,
unpublished results). Therefore our further experiments
were focused on in vitro studies to demonstrate that zinc/
calcium-dependent oligomerization of S100A12 may be
an additional and very important factor contributing to its
target interactions; this was probed on the example of the
best known interaction partner, RAGE.
Surface plasmon resonance
We have exploited surface plasmon resonance technique
to analyze the binding of S100A12 to immobilized RAGE
with different Ca and Zn concentrations in greater detail
in vitro. Our results show that the interaction of these mol-
ecules depends both on Ca and Zn (Fig. 2A–C). More
detailed studies on affinity and on/off-rates could not be
calculated from these SPR curves as they do not fit into
any reliable binding model. Therefore we used immobi-
lized S100A12 to show affinity of the S100A12/RAGE
interaction, which is in the nanomolar range [4.6 × 10-9
M], and calculated kon [6.8 × 104 1/(M×s)], koff [3.2 × 10-
4 1/s] and Chi2 [0.47] values after fitting the response
curve to a 1:1 Langmuir model.
The most likely explanation for the differences in the SPR
results for binding of RAGE to immobilized S100A12 vs
that of S100A12 to immobilized RAGE lies in the different
ways the proteins are attached to the surface. Because we
used amine coupling, we are unable to say for sure how
exactly each of the proteins was attached. We can suppose,
however, that in the case of S100A12-to-RAGE there was
more hindrance of the immobilized protein (in other
words – the recognition site was partially obstructed).
Moreover, each of the proteins could be attached by a
number of different sites, and this possibly complicated
the analysis of the results for the case of immobilized
RAGE. Nevertheless, the main aim of the study, namely,
showing the effect of calcium and zinc on the interaction
between S100A12 and RAGE has been achieved.
Translational Diffusion of S100A12 in the presence of Zn 
and Ca ions
Large biomolecular oligomers scatter light disproportion-
ally stronger than the monomers resulting in a dynamic
light scattering (DLS) bias towards multimers. Solution
NMR experiments are more sensitive to the smaller oli-
gomers, thus, presenting a complimentary approach to
DLS. Pulsed field gradient NMR experiments were used to
measure translational diffusion coefficient of the apo-
form of S100A12 and its divalent complexes with Ca2+
and Zn2+ and Ca2+, respectively. Fitting the experimental
data (Fig. 3) to the theoretical dependence of the signal
attenuation on the strength of the gradient field (Eq 6 and
7), we obtained the values for the translation diffusion
coefficients for apo-, Ca2+, and Ca2+, Zn2+  forms of
S100A12 of 1.12 ± 0.07·10-10 m2/s, 0.95 ± 0.06·10-10m2/
s, and 0.53 ± 0.07·10-10m2/s, respectively. According to
(Eq 5), ratio between translational diffusion coefficients is
inversely proportional to the ratio of hydrodynamic radii
of the oligomers. Based on the NMR data we have
obtained the value for the ratio between radii of
1:1.18:2.11 for apo-S100A12, Ca2+-S100A12, and Zn2+,
Ca2+-S100A12 respectively. This value can be directly
compared to the ratio derived from the DLS data
1:1.25:3.09 (data not shown). The difference between the
DLS and NMR results suggests that binding of divalent
ions to S100A12 produces a complex mixture of exchang-
ing oligomers in solution. Both the size and the relative
population of the oligomers are increasing with the addi-
tion of Zn ions.
Native PAGE
Analysis of relative electrophoresis mobilities in non-
denaturing gels provided a sensitive technique to deter-
mine the oligomerization state of the protein and esti-
mate molecular masses of multiple species. At least two
fast migrating bands could be resolved when apo-
S100A12 was electrophoresed through the native gel (Fig.
4A). In contrast, slower migrating bands could be detected
when the same amount of the protein was run in 2 mM
Ca (Fig. 4B), these possibly corresponded to the tetramers
and a much smaller amount of hexamers. In the presence
of 5 μM Zn the bands possibly corresponded to a
tetramer-hexamer transition (Fig. 4C) and with 10 μM Zn
– hexamers or some degree of aggregation (Fig. 4D). These
bands could represent the tetramers and hexamers that
were suitable for detection by size exclusion chromatogra-
phy and MS. In the presence of both Ca and Zn (Fig. 4E)
only a single band was visible. Both TPEN (zinc-chelator)
and EDTA (divalent ion-chelator), but not BCS (copper I-
chelator) inhibit hexamer-formation (Fig. 4F). S100A12
was next pre-treated with TPEN to remove all zinc from
the preparations. The protein was then dialyzed back into
a Zn-free and TPEN-free buffer, and re-substituted with
Zn, Cu, or Ca before loading the gel. There were no
tetramers/hexamers in the absence of zinc, which is also
not influenced by addition of copper. When re-substitut-
ing Zn, there is a tetramer/hexamer formation, which is
also induced to a lesser extent by adding calcium (Fig.
4G).
Size exclusion chromatography
The influence of zinc and calcium on the changes of the
oligomerization state of S100A12 was analysed by SEC
(size exclusion chromatography). In the absence of the
ions the protein eluted as a dimer, with some trace of aBMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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Surface plasmon resonance analysis of S100A12-RAGE interaction Figure 2
Surface plasmon resonance analysis of S100A12-RAGE interaction. (A and B). Sensorgrams on Ca2+- and Zn2+-
dependent binding of S100A12 to immobilized RAGE. Sensorgrams show association and dissociation with varying conditions 
in which either Ca2+ was kept stable with varying Zn2+ concentrations or vice versa. One representative out of three independ-
ent experiments is shown as response units (RU; y-axis). Time is shown in seconds. (C). Kinetic and affinity analysis of RAGE 
binding to immobilized S100A12. Recombinant human RAGE/Fc (125 nM) was injected over a surface where recombinant 
S100A12 was immobilized at a density of 2,933 RU on a CM5 chip using amine coupling chemistry. Samples were injected for 3 
min at a flow rate of 30 μl/min. HBS-P buffer (Biacore) containing 1 mM Ca2+ and 20 μM Zn2+ was used as sample and running 
buffer. The sensorgram obtained after injection of 125 nM RAGE (straight line) was perfectly fit to a 1:1 Langmuir model (dot-
ted line; BIAevaluation software; Biacore) for calculation of affinity and on-/off-rates. The KD, kon, koff and Chi2 values were 
calculated to: 4.6 × 10-9 M; 6.8 × 104 1/Ms; 3.2 × 10-4 1/s; and 0.47, respectively.
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tetramer. In the presence of EDTA it was a strict dimer.
When the buffer contained 10 μM zinc the protein size
corresponded to a tetramer. With 1 mM calcium it was
mostly a dimer, but with a "shoulder" of a tetrameric frac-
tion, with higher calcium concentration this "shoulder"
reshaped forming a low peak closer to a hexamer, and
finally, in the presence of 10 μM zinc only 2 mM calcium
was enough for a complete transition to a hexameric form
(Fig. 4H).
ESI-MS analysis of S100A12 and its complexes with the 
group IIa and IIb metals
We first determined the capillary potential in the ion
source required to observe metallo-S100A12 complexes in
the gas phase, since excessively high capillary potential
causes dissociation of non-covalent complexes. The
potential was varied between 33 V and 138 V. At a capil-
lary potential of 138 V no dimer peaks were observed;
above 63 V both monomer and dimer peaks were evident
(+4, +5 and +6 charge states) and below 48 V no mono-
mer peaks were observed. We chose to use a capillary
potential of 48 V or less for subsequent experiments [41].
Zn2+-S100A12 complexes were formed by dialyzing a
solution of S100A12 against a range of Zn concentrations.
At Zn concentrations of 1 μM or greater, we observed the
formation of a fully saturated complex containing two Zn
ions per dimer. Dimers containing one Zn ion were also
evident, but the intensity of spectra for dimers containing
two Zn were much more intense. Dimers containing no
Zn ions were also present and the intensity of their spectra
were greater than that of dimers containing a single Zn ion
(Fig. 5A).
The stability of Zn2+-S100A12 dimers was assessed by
increasing the capillary potential to 123 V. At this poten-
tial, dimers containing two zincs ions persisted, whereas
for apo-S100A12, only monomers were evident. Thus,
metal-bound complexes are more stable than apo-com-
plexes in the gas phase that has also been previously
observed by Alfonso et al [42].
We also examined the binding of Cu2+, Ca2+, Fe2+, Ni2+
and Co2+ ions to S100A12 dimers. Fully saturated com-
plexes were formed at Cu concentrations above 10 μM
(not shown) and at calcium concentrations above 100 μM
(Fig. 5B). However, adding Fe2+, Ni2+ and Co2+ did not
result in any new species in the mass spectra (not shown),
suggesting that Cu2+, Zn2+ and Ca2+ binding to S100A12
dimers is specific.
Next we assessed calcium binding to S100A12 dimers in
the presence of 1 μM Zn; at this concentration each
S100A12 dimer contained predominantly two Zn ions. At
1 μM calcium, one or two calcium ions were bound to
S100A12 dimers, whereas no calcium was bound to apo-
S100A12. At a Ca concentration of 10 μM, up to three cal-
cium ions were bound to each S100A12 dimer, and the
average number of calcium ions bound was 1.1 per dimer
versus 0.16 per dimer in the absence of Zn ions. When the
Ca concentration was increased to 100 μM, no signal was
observed, suggesting that larger oligomeric species were
formed. The intensity of each species present at different
calcium concentrations is shown in Fig. 5C. These data
show that bound Zn increases the affinity of the S100A12
dimers for Ca.
To detect oligomeric species in the presence of Ca and Zn
ions, we increased the concentration of S100A12 to 200
μM. Adding 100 μM Zn and 200 μM Ca produced
S100A12 dimers, tetramers and hexamers (Fig. 5E).
Increasing the concentration of Zn and Ca ions to 200 μM
and 400 μM (Fig. 5F), respectively, shifted the equilibria
towards the higher order oligomers, with hexamers as the
dominant species and dimers almost absent from the
spectrum. Hexamers were observed in the +16, +17 and
+18 charge states, while tetramers were observed in the
+13, +14 and +15 charge states. Spectra with no metal
ions contained dimers and some tetramers, but no hex-
amers (Fig. 5D).
The total ion signal intensity decreases with increasing
concentrations of metal ions. This decrease correlates with
Decay of the integrated NMR signal intensity Figure 3
Decay of the integrated NMR signal intensity. of the 
apo-S100A12 (squares), Ca2+-S100A12 (circles), and Zn2+, 
Ca2+-S100A12 (triangles) as a function of the magnetic field 
gradients. Proton NMR signal was integrated over the amide 
region (from 6.5 ppm to 10.5 ppm). The translational diffu-
sion coefficients for the apo-S100A12, Ca2+-S100A12, and 
Zn2+, Ca2+-S100A12 determined by curve fitting to equation 
1, were 1.12 ± 0.07·10–10 m2/s, 0.95 ± 0.06·10–10 m2/s., 
and 0.53 ± 0.07·10–10 m2/s, respectively.BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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the binding affinity of the ions for S100A12 (data not
shown). For example, to decrease the signal intensity by
50%, Zn, which binds to S100A12 with the highest affin-
ity, required the lowest concentration (1 μM) followed by
Cu (10 μM) and Ca (100 μM). The most likely explana-
tion for this decrease is protein aggregation. Results using
DLS and size exclusion chromatography confirm the pres-
ence of highly oligomerised species. Finally, the presence
of a substantial population of tetrameric intermediates
suggests that formation of S100A12 hexamers may not be
cooperative as is the case for the formation of insulin hex-
amers [43].
Tyrosine fluorescence titration of S100A12 with bivalent 
metal cations
We used intrinsic protein fluorescence as a sensitive
assessment of ion binding and changes in protein confor-
mation. Two tyrosine residues, Y17 and Y86 contribute to
the intrinsic fluorescence of S100A12. We monitored the
changes in tyrosine fluorescence as a result of titration
with Ca2+, Zn2+ and a combination of Ca2+ and Zn2+. The
addition of 50 μM EDTA into the solution of S100A12 did
not result in any noticeable change in the protein fluores-
cence (data not shown) that confirmed the apo-state of
the prepared and purified protein. Titration of S100A12
Native PAGE and overlay of size-exclusion chromatograms of S100A12 in the presence of EDTA and different cations Figure 4
Native PAGE and overlay of size-exclusion chromatograms of S100A12 in the presence of EDTA and different 
cations. Loading concentration of S100A12 – 14 μg (A-E). Dimeric S100A12 is indicated by an arrow. Concentrations of zinc 
acetate and calcium chloride are indicated above the gel picture. (F) TPEN (zinc-chelator), BCS (copper I-chelator), or EDTA 
(divalent cation chelator) was added. After removal of calcium or zinc from the buffer solution the dimeric S100A12 is the 
strongly preferred form, while removal of copper did not produce a measurable effect. (G) S100A12 in a zinc- and calcium-free 
solution was re-substituted with zinc, copper, or calcium before loading the gel. There were no hexamers in the absence of 
zinc (w/o), which is also not influenced by addition of copper. When re-substituting zinc, there is predominantly a hexamer for-
mation, which is also induced to a lesser extent by adding calcium, where a second band eventually representing tetrameric 
S100A12 can be observed. (H) SEC was performed using Akta FPLC chromatography equipment (Amersham Pharmacia Bio-
tech) and a Superdex 200 (10 mm×300 mm) gel-filtration column (Amersham Pharmacia Biotech). Before each run the column 
was equilibrated with elution buffer 50 mM Tris, pH 7.5, 200 mM NaCl. The flow rate was 0.5 ml/minute and the protein elu-
tion was monitored by UV-absorption at 280 nm. S100A12 Abs 280/260 = 0.4/0.3. S100A12 elutes as a dimer in the presence 
of EDTA (shown in violet), shows a tendency to oligomer formation at increasing calcium concentrations (red and blue 
curves), elutes as a tetramer in the presence of zinc (orange), and as a hexamer with calcium and zinc (green).
F G
TPEN Zn2+ 10μM BCS EDTA
5mM Ca2+ 1mM 5mM 5mM
Zinc-depleted S100A12
Zn2+ Ca2+ Cu2+ w/o
10μM 1mM 1mM
HBMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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with Ca at pH 7.4 (10-mM HEPES buffer) resulted in a
gradual decrease in the tyrosine fluorescence intensity
(Fig. 6A, B) with a minor peak shift of 1–2 nm (Fig. 6A).
The change in the intrinsic tyrosine fluorescence intensity
with Ca2+ was well fit to one-site binding model (eq. 1).
Since S100A12 has two Ca2+ sites, we assume that one site
does not affect the tyrosine fluorescence. This is in agree-
ment with similar observations we have made earlier
[unpublished data] for S100A4 protein and its mutants
lacking N-terminal or C-terminal tyrosines. The best fit
gave an estimated value of K = (5.9 ± 1.7)*104 M-1 for the
equilibrium constant of the Ca2+ binding reaction. This
value was higher than the previously reported one, (1.9 ±
0.4)*104 M-1 for pig granulocytes S100A12 at pH 7.4 in
Tris-HCl buffer [31]. For comparison, we repeated the flu-
orescence titration experiment in 25-mM Tris-HCl (pH
7.4) buffer and obtained the value of (1.2 ± 0.7)*104 M-1,
which is consistent with the previously reported result.
In contrast to calcium, S100A12 titration with zinc
resulted in non-monotonic changes in tyrosine fluores-
cence that might indicate the occurrence of at least two
different binding sites for this ion. However, (i) the pre-
dominant dimeric appearance of apo-S100A12 and (ii)
strong protein aggregation in the presence of a small
amount of Zn complicates the interpretation of the fluo-
rescence titration data (see Discussion). As shown in Fig.
6C, the peak fluorescence intensity decreases sharply by
~5% at low Zn2+ concentrations (from 2 μM to 6 μM) and
increases at higher concentrations reaching a level exceed-
ing the initial intensity by ~10% at sub-millimolar Zn
concentrations (intensity changed from 309→295→337
Mass-spectrometry of S100A12/metal complexes Figure 5
Mass-spectrometry of S100A12/metal complexes. Bar charts showing the number of metal ions observed to be bound 
to the S100A12 dimers when S100A12 was dialyzed against a range of metal ion concentrations and analyzed by ESI FTICR 
mass spectrometry. (A) A range of Zn2+ concentrations; control was a solution with no metal ions; (B) a range of Ca2+ concen-
trations; (C) a range of Ca2+ concentrations in the presence of 1 μM Zn2+. All charts show the sum of the intensities for each 
metal ion number, summed over all charge states present. (D) ESI FTICR mass spectra of 200 μM S100A12 with no metal ions 
added; (E) 100 μM ZnCl2 and 200 μM CaCl2 added; (F) 200 μM ZnCl2 and 400 μM CaCl2. D = S100A12 dimers, T = S100A12 
tetramers, H = S100A12 hexamers.
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a.u.). It is interesting, that previously, a steady increase in
fluorescence intensity for Zn titration curves has been
reported for S100A12 obtained from pig granulocytes,
and a single high affinity Zn2+ binding site per a monomer
has been proposed. A non-monotonic fluorescence
change on zinc titration has been reported also for
S100A8/A9 proteins [44]. Obviously Zn2+ induced differ-
ent conformational changes of S100A12 compared to
Ca2+. Zn2+ titration data fitted well to two-binding site
model (eq. 3) with the stability constants of (4.5 ±
0.8)*105 M-1 and (7.5 ± 1.7)*103 M-1.
Interestingly, the initial decrease in the fluorescence inten-
sity at low Zn2+ concentration (2 μM-6 μM) in the absence
of Ca2+ (Fig. 6C) disappeared in the presence of 180 μM
Ca2+(Fig. 7B). Upon addition of Zn2+ to the Ca-loaded
S100A12, a gradual increase was observed (Fig. 7B),
which is consistent with the previous result reported for
Zn2+ titration to pig granulocytes apo-S100A12 [31]. The
reverse titration of Ca2+ to Zn2+-loaded protein at low (3
μM, Fig. 8A) and high (200 μM Zn2, Fig. 8B) showed
diverse effects. Sharp decrease in the fluorescence inten-
sity (Fig. 8B) was observed when protein was fully satu-
rated with zinc, which is consistent with the previous
result that Zn2+ increases Ca2+ affinity to pig granulocytes
S100A12 protein. Calcium titration curve for the protein
at low zinc concentration was completely different, with a
very gradual increase of the intensity (Fig. 8A); this could
be interpreted as weak calcium binding to the aggregated
protein. It is noteworthy here that we are not reporting on
the quantitative aspects of Ca2+ and Zn2+ binding (exact
Tyrosine and TNS fluorescence of S100A12/metal complexes Figure 6
Tyrosine and TNS fluorescence of S100A12/metal 
complexes. (A) Intrinsic tyrosine fluorescence spectra of 
apo-S100A12 (2.5 μM), and S100A12-Ca2+ and S100A12-
Zn2+ complexes in 10 mM pH 7.4 Hepes buffer, at total 
metal ion concentration of 275 μM and 244 μM, respectively. 
(B and C) Fluorescence titration of apo-S100A12 with Ca2+ 
and Zn2+.
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Tyrosine and TNS fluorescence of S100A12/metal complexes Figure 7
Tyrosine and TNS fluorescence of S100A12/metal 
complexes. (A) TNS Fluorescence spectra of S100A12-
Ca2+, S100A12-Zn2+ and S100A12-Zn2+-Ca2+ complexes in 
10 mM pH 7.4 Hepes buffer, at total metal ion concentration 
of 180 μM (Ca2+) and 200 μM (Zn2+). (B and C) Fluores-
cence titration of apo-S100A12 first with Ca2+ up to the total 
concentration of 180 μM and then with Zn2+. S100A12 con-
centration was 2.5 μM, and TNS concentration was 20 μM.
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number of binding cations per protein molecule) but pre-
senting qualitative fluorescence data, which show that the
presence of zinc ion can dramatically change the affinity
and fluorescence response to calcium ion.
TNS fluorescence titration of S100A12 with metal ions
A large increase in TNS fluorescence intensity was
observed on titration of apo-S100A12 with metal ions,
however, Zn2+ induced a much larger change than cal-
cium. In addition, the TNS fluorescence peak showed a
blue shift in the presence of Zn relative to the fluorescent
peaks obtained in the presence of calcium (Fig. 7A). The
latter may indicate the accessibility of a larger hydropho-
bic surface to TNS upon Zn2+ binding.
In contrast to the intrinsic tyrosine fluorescence, TNS indi-
cated a one-step reaction only on S100A12 titration with
Zn2+. TNS florescence intensity increased sharply when
Zn2+ concentration increased from ~1 μM to ~6 μM and
did not change upon further Zn2+ addition (Fig. 6C). In
other words, TNS was sensitive to the S100A12 structural
rearrangements caused by the binding of the first cation,
but showed no changes due to the binding of a second Zn
ion. However the binding of the second Zn2+ ion resulted
in a substantial increase in the intrinsic tyrosine fluores-
cence intensity. The addition of a small amount of Zn2+ to
Ca2+-loaded S100A12 did result in protein structural
changes and the appearance of an accessible hydrophobic
surface since the TNS fluorescence showed a sharp change.
Furthermore, the observed blue shift of TNS fluorescence
peak upon Zn2+ binding to apo S100A12 protein disap-
peared in the case of Zn2+-Ca2+-S100A12 complex (Fig.
7A). A TNS fluorescence titration of Zn2+-S100A12 com-
plex with Ca2+ confirmed this observation by showing the
obvious red shift upon addition of Ca2+ with no intensity
change (data not shown). These results indicated that the
TNS binding sites formed as a result of complex formation
between S100A12 and Zn2+  alone was different from
those between S100A12, and Zn2+ and Ca2+ together.
Mapping of the Zn2+ binding surface by NMR spectroscopy
Ca2+-S100A12 was extensively studied by NMR spectros-
copy [20]. We decided to further utilize this technique to
obtain atomic resolution information on the structural
elements of Ca2+-S100A12 involved in binding Zn2+.
NMR chemical shift perturbations technique is exquisitely
sensitive to the changes in the protein structure upon
complex formation. Depending on the nature of the
molecular interactions, protein complex formation may
result in either changes in the position of the NMR peaks
or their broadening. Both changes can be mapped onto
the three-dimensional structure of the protein delineating
the interaction surface.
Titration of [U-, 15N] Ca2+-S100A12 with Zn2+ ion resulted
in the dramatic uniform increase of the line broadening of
the 1H{15N}-HSQC spectrum. (Fig. 9A). This suggests that
the protein complex with Zn2+ forms large aggregates,
consistent with our previous observation. After the
metal:protein ratio (w/w) reached 1.3:1, there were no
more changes in the NMR spectrum. This ratio is consist-
ent with one Zn2+ ion binding to Ca2+-S100A12 monomer
observed in our ESI-MS study.
In spite of the obvious increase in the size of Zn2+Ca2+-
S100A12 compared to Ca2+-S100A12, the majority of its
amide protons and nitrogens did not change significantly
their chemical shifts. 53 out of 82 amide hydrogen and
nitrogen peaks observed in 1H{15N}-HSQC spectrum of
[U-, 15N] Ca2+-S100A12 changed their chemical shifts
less than 0.05 ppm. This observation suggested that com-
plexation with Zn2+ did not result in dramatic change of
the overall structure of Ca2+-S100A12 dimer. Structural
elements that did not undergo significant changes due to
binding to Zn2+ include loop I, helix II, loop II, helix III
and linker loop. Since these elements are involved in
binding Ca2+, we assumed that Ca binding sites were
largely intact in Zn2+, Ca2+-S100A12. Amide peaks that
underwent either large chemical shift changes (more than
0.1 ppm) or disappeared due to broadening are located in
two structural elements: helix I and helix IV. These ele-
Intrinsic tyrosine fluorescence titration Figure 8
Intrinsic tyrosine fluorescence titration. of S100A12-
Zn2+ with Ca2+ in 10 mM pH 7.4 Hepes buffer. S100A12 con-
centration was 2.5 μM.
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ments formed a contiguous surface when we mapped
them on the ribbon diagram of Cu2+, Ca2+-S100A12
dimer (Fig. 9B). The same structural elements are involved
in the binding of Cu2+ ion in the Cu2+, Ca2+-S100A12 crys-
tal structure. Thus, NMR data provided strong evidence
that Zn ion bound to the Cu2+ binding site. We may also
expect that structural changes associated with Cu2+ bind-
ing, extension of the helix 4 and restructuring of the target
binding surface, would be similar for binding Zn2+.
Discussion
Our in vitro experiments highlighted how the oligomeriza-
tion of S100A12 can be modulated by the binding of Ca
and Zn ions. The results revealed that Zn binding induces
a significant change in protein quaternary structure. The
dramatic effect of Zn ions on the S100A12 conforma-
tional changes provides a rationale for the diverse target
binding capability of S100A12 protein.
It was found that S100B bound its target peptide TRTK-12
both in a Ca loaded mode and in a Zn2+-Ca2+-mode, but
not in the complex with Zn [45]. It was proposed that the
protein did not adopt the right conformation to recognize
this target in the presence of Zn2+ alone. It seemed likely
that Ca binding specifically arranged the target-binding
region into a shape which enhanced target binding affin-
ity and that these local conformational changes were crit-
ical for target protein binding.
The information obtained in our previous studies indi-
cated the importance of the relative position of helices III
and IV for target protein binding [46]. NMR chemical shift
mapping showed that zinc binding led to the restructuring
of helices I and IV, and induced the exposure of a number
of hydrophobic residues. In fact, the location of the chem-
ical shift changes due to Zn binding matched that
involved in Cu binding.
We predicted that a pair of Zn binding sites situated within
a dimer would be located at the same position where cop-
per binds in the S100A12-copper structure (PDB code
1ODB; Fig. 10A, B). These sites had a high sequence-struc-
ture similarity with the zinc binding sites of several other
S100 proteins. A single Zn2+- binding site per monomer
was first identified for porcine S100A12 by fluorimetric
titration, and a C-terminal HisxxxHis Zn-binding motif was
proposed based on sequence analysis and secondary struc-
ture prediction [31]. The crystal structure of S100A7
revealed the location of the Zn-binding site, which was
composed of an N-terminal histidine and an aspartic acid
from one subunit and two C-terminal histidines from a sec-
ond subunit (Fig. 10B). Sequence comparison suggested
that S100A8, S100A9, S100A12 and S100B could have sim-
ilar Zn-binding sites [24]. Involvement of the C-terminal
Mapping of the interaction surface involved in the Zn2+Ca2+- S100A12 complex formation using NMR chemical shift per- turbations Figure 9
Mapping of the interaction surface involved in the 
Zn2+Ca2+-S100A12 complex formation using NMR 
chemical shift perturbations. (A) Overlay of the 
1H{15N}-HSQC spectra of [U-, 15N] Ca2+-S100A12 (black) 
and [U-, 15N] Zn2+, Ca2+-S100A12 (red) shows that 54 out of 
80 amide peaks do not significantly change their position 
upon addition of Zn2+ to Ca2+-s100a12. Significant spectral 
broadening of the Zn2+, Ca2+-S100A12 peaks is due to the 
increased molecular weight of the oligomer. (B) Amino acids 
of the Zn2+, Ca2+-S100A12, whose amide peaks are either 
completely broadened or underwent large (> 0.1 ppm) 
chemical shift change, are mapped onto the backbone of 
crystal structure of the Cu2+, Ca2+-S100A12 dimer (PDB 
code 1ODB. They are shown in red and cluster around Cu2+ 
binding motif suggesting that this motif is also involved in  
Zn2+-binding. Amino acids that are not involved in Zn2+-bind-
ing are shown in cyan.BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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HisxxxHis motif of S100A8, S100A9 and S100A12 in zinc
binding had previously been predicted on the basis of
sequence alignment [5]. In addition, based on sequence/
structure comparisons, it is possible that S100A6 bound
zinc in a similar way, although it lacked one of the C-termi-
nal zinc-binding residues.
The same binding site was identified in the NMR and X-
ray structures of zinc-loaded S100B [25,47] (PDB codes
1XYD, 3CR2; Fig. 10B). Binding of Zn2+ and Cu2+ resulted
in some similar conformational changes upon formation
of Zn2+-S100B and Cu2+-S100A12 complexes. Significant
changes at the putative target-binding site upon copper
binding were observed for S100A12 protein, including the
extension of the C-terminal helix and closer contacts
between dimers [46]. These changes were also observed
for S100B upon Zn2+ binding. However, no changes in the
interhelical angle similar to those observed in S100B-
Ca2+-Zn2+ system were found upon addition of Cu2+ to the
S100A12-Ca2+ complex. Thus, the binding of copper and
zinc may result in different changes in the target binding
site.
TNS fluorescence data have demonstrated a significant
difference between three ion loading modes of S100A12.
In particular, a blue shift in the TNS fluorescence peak was
found for Zn2+-S100A12 complex which was not evident
for either Ca2+ nor Zn2+-Ca2+ bound proteins. Hydropho-
bic amino acid residues responsible for this blue shift
might contribute to different conformations of Zn2+-
S100A12 and Zn2+-Ca2+-S100A12. We tentatively
attribute the blue shift in TNS fluorescence to a stronger
hydrophobic environment experienced by the TNS mole-
cules bound to Zn2+-S100A12 complexes. In the case of
Zn2+  bound S100A12, analysis of the amino acid
sequences of Helix III and Helix IV, the linker loop, the C-
terminus and the N-terminus of the other subunit, all of
which contribute to the target binding site, pointed to Lys
residues with long hydrocarbon chains as the possible
candidates for contributing to the blue shift of the TNS
fluorescence peak. A huge observed increase in TNS fluo-
rescence upon Lys-TNS binding in water (data not shown)
caused us to conclude that the orientation between Helix
III and IV, which buries certain Lys residues, may be criti-
cal for target protein binding. These could be the Lys resi-
dues from the linker loop (or "hinge" region) – region
between helices III and IV, the importance of which for
S100A12 function has recently been confirmed [13].
Tyrosine fluorescence titration experiments suggested the
presence of at least two Zn-binding sites in S100A12 with
significantly different affinities. However, a large increase
in TNS fluorescence was evident only at the first stage of
titration with Zn. Our previous studies indicated that TNS
was more sensitive to aggregation due to hydrophobic
interactions than just the appearance of accessible hydro-
phobic surfaces [20]. Therefore, TNS fluorescence titration
might indicate a strong aggregation of S100A12 at low
Zn2+ concentrations. We hypothesize that even one Zn2+
per dimer is sufficient to induce the aggregation. Binding
a second Zn2+ per dimer occurs under aggregated condi-
tions and might exhibit a different affinity despite the
binding site (considering the S100A12 monomer) being
the same. This hypothesis agrees well with both NMR (see
Fig. 9B and figure legend) and ESI-MS data (Fig. 5).
Our surface plasmon resonance studies revealed that
indeed the interaction of S100A12 with its cell surface
receptor RAGE was facilitated with increasing Ca and Zn
concentrations, likely due to the fact that under these con-
ditions more oligomers formed which could bind to
RAGE. Available data in vitro and in vivo open the possibil-
ity that the cellular pool of Zn may be sufficient to bind to
S100 proteins. Zn ions are generally tightly bound by the
proteins [48,49] and it has been proposed that Zn is nor-
mally transferred directly from a donor to an acceptor
molecule. However recent studies have demonstrated the
importance of weakly bound Zn [50]. The physiological
significance of potential intracellular S100A12 aggrega-
tion in the presence of very low concentrations of zinc
Comparison of zinc and copper binding sites in S100 proteins Figure 10
Comparison of zinc and copper binding sites in S100 
proteins. (A) Human S100A12 dimer in the copper-bound 
state (PDB code 1ODB). Ribbons of the two subunits are in 
yellow and purple. Calcium ions are shown in grey and cop-
per ion in cyan. Copper-binding residues are shown in ball 
and stick. (B) Superposition of the copper (and potentially 
zinc) binding site in S100A12 on zinc-binding sites of S100A7 
(PDB code 2PSR) and S100B (PDB code 3CR2). Copper-
binding residues of S100A12 and copper ion are in yellow, 
corresponding residues and zinc are in green for S100A7 and 
in cyan for S100B. The structures were superimposed using 
the program LSQKAB [59]. Part A of the figure was gener-
ated using MOLSCRIPT [60] and rendered with Raster3D 
[61], part B with CCP4mg [62]
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ions has a rational explanation. In resting neutrophils the
level of Ca is very low and is not enough to saturate any of
the S100 proteins with Ca. The binding of zinc to
S100A12 may lead to its localization in large oligomeric
form (larger than hexamers), thus preventing the free dis-
tribution of S100A12 within the cytoplasm and leading to
its accumulation in specific locations. In addition, the
presence of Zn may increase the sensitivity of S100A12 to
Ca up to 1500 fold. This phenomenon has been con-
firmed for both human and pig S100A12. Ca import into
cells activates S100A12 to bind to its putative transporter
and/or to other intracellular targets and to translocate
toward the cellular membrane (Fig. 11). The calcium acti-
vated translocation has been demonstrated by Guignard
et al[4]. A very interesting hypothesis [32] based on the
earlier work [51,52] has been suggested; that at low oxida-
tive stress several Zn-binding proteins may release free Zn
and that this Zn is able to regulate the activity of S100 pro-
teins. Under oxidative conditions in neutrophils, it is pos-
sible that Zn ions released from the cysteine-containing
Zn binding proteins could be accepted by other proteins
with histidine Zn binding motifs. Due to the high level of
expression in neutrophils S100A12 may be a good accep-
tor of escaped zinc. We proposed that S100A12 is also reg-
ulated in the same manner by binding various amounts of
zinc and changing its oligomeric status. On the other
hand, the binding of S100 proteins to Zn attenuates a
potential toxicity by sequestering Zn ions. Outside the cell
where Zn concentration depends on the local microenvi-
ronment and the Zn level can rapidly rise and fall, all
types of S100A12 oligomers may exist in equilibrium
depending on the local Zn concentration. This may
explain how S100 proteins are managed to specifically
interact with different extracellular receptors supporting
and regulating signal transduction pathways (Fig. 11).
Oligomeric S100A12 species have been discovered in
blood serum [53] and in human tissues [17]. The latter
study investigated the presence and deposition of
S100A12 and other family members in familial (PS-1)
and sporadic AD cases. In all cases 70-kDa S100A12 spe-
cies have been found. The higher affinity of oligomeric
S100A12 to RAGE demonstrated in our recent and current
studies could explain the elevated level of S100A12 high-
molecular weight species in AD brain samples. The chang-
ing extracellular environment is a mechanism that may
effectively modulate the structural properties of S100A12
and its ability to bind RAGE.
The existence of zinc binding sites in S100 proteins that
are able to transmit signals through RAGE and other puta-
tive extracellular receptors raises a very important ques-
tion about the role of S100 proteins in the cross-talk
between zinc and calcium. In this model the role of S100
signalling is likely to be similar to the role of Zn sensing
receptors. S100 signals could be accepted by extracellular
receptors coupled with G-proteins, with further activation
of PLC and a rise in Ca concentration. It was demon-
Graphical representation of hypothetical mechanism on the effect of calcium and zinc on the S100A12 assembly, translocation  and interaction with extracellular targets Figure 11
Graphical representation of hypothetical mechanism on the effect of calcium and zinc on the S100A12 assem-
bly, translocation and interaction with extracellular targets.BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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strated that the cellular response to S100A12 was abol-
ished by inhibitors of phospholipase C (PLC), protein
kinase C (PKC), Ca2+ flux and Ca2+/calmodulin depend-
ent kinase II [54].
This hypothesis provides a simple integration mechanism
that is able to transmit a signal from the cellular microen-
vironment when local changes of Zn concentration and
pH are generated by physiological and pathophysiologi-
cal events.
Methods
Protein Expression and Purification
S100A12
Recombinant full-length human S100A12 was expressed
in  E. coli from the modified pQE60 vector containing
S100A12 gene. Although the pQE60 vector contains a
6×His sequence a stop codon was deliberately inserted so
that the protein was expressed without a histidine tag.
Protein expression was induced with 1 mM IPTG and the
bacterial pellet was lysed by sonication. After sonication
the insoluble material was removed by centrifugation. The
supernatant was adjusted up to 10 mM CaCl2 and after 15
min incubation at room temperature was clarified by cen-
trifugation. Clear supernatant was applied onto Phenyl-
Sepharose column equilibrated with 50 mM Tris-HCl (pH
7.5), 150 mM NaCl, 5 mM CaCl2, the protein was eluted
with 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM
EDTA. S100A12 containing fractions were concentrated
by ultrafiltration in an Amicon centrifugation filter unit
(Millipore) buffer-exchanged into 50 mM Tris-HCl pH 7.9
buffer, and applied to a 1 ml ResQ column (Pharmacia),
equilibrated with 50 mM Tris-HCl pH 7.9 buffer. The pro-
tein was eluted with a 0–1 M NaCl gradient using an AKTA
Purifier chromatography system (Amersham). Protein
concentration was determined by BCA protein assay (Bio-
Rad). After purification a single 10 kDa band was
observed on the SDS-PAGE.
Extracellular domain of RAGE
Recombinant soluble extracellular fragment of human
RAGE (aa 24–336) was purified according to recently
described protocol [20].
The molecular masses of the purified proteins were verified
by mass spectrometry (MALDI) giving peaks of 37213 Da
for RAGE with His-tag, 35190 Da for RAGE with cleaved
His-tag and 10642 Da for S100A12. These values are in
close agreement with the calculated molecular masses.
Near-Field Scanning Optical Microscopy (NSOM)
The human gastric cancer cell line MKN74 was obtained
from the Health Science Research Resources Bank (Japan
Health Sciences Foundation, Osaka). MKN74 is a cell line
established from moderately differentiated adenocarci-
noma.
MKN74 cells were cultured on 18-mm glass coverslips for
16 h, then washed with a fresh medium without serum
and incubated in the presence of 10 μg/ml S100A12 at
10°C in F12 and RPMI 1640 cell culture medium without
serum. After incubation cells were washed three times
with PBS (pH 7.4), fixed with 3% paraformaldehyde, 2
mM MgCl2 and 4% sucrose at room temperature for 20
min, incubated in 0.15 M glycine in PBS and washed
again with PBS. Then one set of coverslips was incubated
in PBS and served as the no-primary antibody control.
Additional control was used in the absence of exogenous
S100A12. Both controls did not reveal any clusters on the
cellular surface. The experimental set was incubated in the
presence of 5 μg/ml rabbit affi-pure anti S100A12 anti-
body at room temperature 45 min. The antibody solution
was aspirated and the cells were washed three times for 3
min with PBS. All coverslips were then incubated with sec-
ondary chicken anti-rabbit Alexa488 labelled antibody
(Invitrogen/Molecular Probes) at room temperature 45'- 1
h. For NSOM imaging, after the three washes with PBS,
the cells on 18-mm coverslips were rinsed three times
with distilled autoclaved water and allowed to air-dry for
a minimum duration of 12 h before imaging.
Bent NSOM probes were prepared from high GeO2-doped
fibers with a core diameter of 3 μm using a two-step chem-
ical etching method followed by aluminum deposition
and focused ion beam milling to produce a flat circular
aperture [55,56]. Probes with aperture diameter of ~100
nm were used in the present work (estimated from SEM
images). The estimated spring constant for these probes is
~100 N/m [55].
NSOM experiments were carried out on a combined AFM/
NSOM microscope based on a Digital Instruments Bio-
scope mounted on an inverted fluorescence microscope
(Zeiss Axiovert 100). A separate x-y piezo scanner (Polytec
PI, Auburn, MA, 50 nm lateral scan range) was used for
sample scanning. A continuous wave mixed gas ion laser
(Coherent, Innova 70 Spectrum) was used for excitation
purposes (488 or 568.5 nm, 20 mW, linear polarization).
NSOM signal was collected with 63 × (0.75 NA) objective,
with appropriate band pass (Omega Optics) and notch fil-
ters (Kaiser Optical Systems, Ann Arbor, MI) to remove
residual excitation and red alignment laser light and
detected using an avalanche photodiode detector (Perkin
Elmer Optoelectronics, SPCM-AQR-15, Vaudreuil, Can-
ada). Images were recorded in tapping mode at a scan rate
of 0.25 Hz and a resolution of 512 × 512 pixels. Images
were processed using standard Nanoscope software as
well as Image J software (NIH). Cluster size analysis was
performed using original non-processed NSOM images
with custom-made software. The software allows the
determination of the number of clusters, their location in
the image, as well as their height (intensity) and
halfwidth.BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
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Immunofluorescence Microscopy
For S100A12 immunofluorescence microscopy, MKN74
cells were cultured in a 8-well LAB-TEK® Permanox chamber
slide (Nalge Nunc International, Naperville, IL) for 16 h,
then washed with a fresh medium without serum and incu-
bated in the presence of 10 μg/ml S100A12 at 10°C in F12,
F12K or RPMI 1640 cell culture medium without serum.
(F12 medium contains Zn2+ [3.5 μM] and Ca2+ [0.3 mM]
and Cu2+ [10 nM]; F12K medium contains Zn2+ [0.6 μM]
and Ca2+ [0.9 mM] and Cu2+ [9 nM]; RPMI 1640 medium
contains Ca2+ [0.55 mM]. No zinc and copper).
After incubation cells were washed with PBS (pH 7.4),
fixed with 3% paraformaldehyde, 2 mM MgCl2 and 4%
sucrose at room temperature for 20 min, incubated in
0.15 M glycine in PBS and washed again with PBS. The
cells were then blocked with 7% serum in PBS at room
temperature and incubated with affinity purified rabbit
anti-S100A12 (kindly provided by A Larsen) in PBS con-
taining 1% serum for 1 h, followed Alexa-594 labeled
chicken anti-rabbit IgG (Molecular Probes, Invitrogen)
diluted 1:1000. The specimens were washed and mounted
using Dako fluorescent mounting medium. Double-labe-
ling immunofluorescence was visualized using Carl Zeiss
Laser Scanning Confocal System (LSM 510, equipped
with a C-Apochromat 63 ×/1.2 W corr objective).
Fluorescence
LS-55 luminescence spectrometer from Perkin Elmer was
used for fluorescent studies. The measurements were
made in a 1 × 1 cm·cm quartz cell at 25°C. The resulting
titration curves were analyzed using SPSS (Lead Technol-
ogies Inc.) and Mathcad 2001 Professional (Mathsoft
Inc.) software.
Tyrosine fluorescence was measured using 255-nm excita-
tion keeping the excitation and emission slits at 5 and 10
nm, respectively. For the metal titration experiments,
S100A12 solutions were prepared at 2.5 μM concentra-
tion in pH 7.4 (for both Ca2+ and Zn2+) and 10 mM
HEPES buffer. Ca2+ (2 mM), Zn2+ (2 mM) stock solutions
were added to S100A12 samples to get final metal concen-
trations of 400 μM, and 50 μM, respectively. Zn2+ titration
of Ca2+-S100A12 complex solution was performed at pH
7.4, 10 mM HEPES buffer. 365-nm excitation and 5/8-nm
excitation/emission slits were used for all the TNS fluores-
cence measurements. All solutions for titration experi-
ments were prepared in the same way as those for tyrosine
fluorescence measurements except that 20 μM of TNS was
added to the 2.5-μM S100A12 solutions.
Data analysis
The fluorescence intensity (F) was corrected for sample
dilution. The apparent association constants K of Ca2+
with S100A12 were calculated by fitting the relative fluo-
rescence intensity F to the function (Eq. 1)
derived from a one-site-binding model (Eq. 2) using SPSS
program, in which f1 is the fluorescence at zero ligand con-
centration, f2 is the fluorescence of the complex, N is the
initial protein concentration, W is the total metal ion con-
centration.
The apparent association constants K  of Zn2+  with
S100A12 was calculated by fitting the relative fluorescence
intensity F to the function (Eq. (3) derived from a two-
site-binding model (Eq. (4) using SPSS program.
Where f1 is the fluorescence of the protein at zero ligand
concentration, f2 is the fluorescence of complex PM, f3 is
the fluorescence of the complex PM2, K is the association
constant of the complex PM, L is the association constant
of the complex PM2. M is the total metal ion concentra-
tion.
SPR RAGE-S100A12 binding assay
Human RAGE-Fc fusion protein (R&D Systems Inc. Min-
neapolis, MN) or alternatively recombinant human
S100A12 was immobilized by amine coupling at low den-
sity on a carboxymethylated dextran-coated CM5 gold
sensor surface. Recombinant human S100A12, overex-
pressed in E. coli was analyzed for binding to immobilized
RAGE in 10 mM HEPES, pH 7.4, and 0.1 M NaCl, and dif-
ferent concentrations of Zn2+ and Ca2+ using the surface
plasmon resonance (SPR) technology (BIAcore 3000 from
Biacore, Uppsala, Sweden). Interactions were monitored
for 3 min using a flow rate of 30 μl/min. The sensor sur-
face was then washed with the same buffer to start the dis-
sociation for 3 min, and the chip was finally regenerated
with a 30 s pulse of 10 mM glycine-HCl, pH 2.1 at 30 μl/
min. To calculate affinity and on-/off-rates of the
S100A12/RAGE interaction human RAGE/Fc was injected
over immobilized S100A12 in a HBS-P buffer containing
1 mM Ca2+ and 20 μM Zn2+. The sensorgram obtained was
fitted to a 1:1 Langmuir model (BIAevaluation software;
Biacore).
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Native Gel Electrophoresis
Native (nondenaturing) polyacrylamide gel electrophore-
sis (PAGE) was performed at a constant voltage (100 V)
with a Hoefer electrophoresis system using a Tris-HCl
7.5% polyacrylamide resolving gel, and Tris-Glycine run-
ning buffer, pH 8.8. Samples were prepared in the absence
or presence of zinc and calcium. In the presence of zinc
and calcium alternatively the zinc-chelator NNNN-tet-
rakis (2-pyridylmethyl) ethylenediamine (TPEN), the
divalent ion chelator ethylenediaminetetra-acetic acid
(EDTA), or the copper I-chelator bathocuproine sulfonate
(BCS) were used to deplete the respective metal ions from
solutions. All chelating agents were purchased from
Sigma, Schnelldorf, Germany. Gels were stained with
Coomassie R250.
Size exclusion chromatography (SEC)
Gel-filtration chromatography was carried out using
Superdex 200 HP 10/30 column (Amersham Pharmacia
Biotech) controlled by an AKTA FPLC system (Amersham
Pharmacia Biotech) and UNICORN 5.0 software. The col-
umn was equilibrated with 2 column volumes of gel filtra-
tion buffer (200 mM NaCl, 50 mM Tris-Hcl pH 7.5) in the
presence or absence of different concentrations of zinc
and/or calcium. The column was run at 20°C at 0.6 ml/
min. Molecular markers used for column calibration were
19.7 KDa (chymotrypsinogen), 45.8 KDa (ovalbumin)
and 67 KDa (albumin). The concentration of the injected
protein was 1 mg/ml, injection loop size 200 μl. The elu-
ate was monitored by absorbance at 215 and 280 mm and
the collected fractions analyzed by SDS-PAGE.
Mass spectrometry
All mass spectrometric measurements were made on a
Bruker (Bruker Daltonics, Billerica, MA, USA) APEX II 9.4
tesla FTICR mass spectrometer, which has previously been
described [57]. The ESI source used was from Analytica
(Analytica of Branford, Branford, USA). The needle that
contained the analyte solution was positioned off-axis;
carbon dioxide was used as a nebulising gas. The solution
was pumped at a flow rate of 100 μl hour-1. Carbon diox-
ide heated to 250°C was used as a drying gas.
S100A12 protein was prepared for ESI mass spectrometry
by desalting over a PD10 column (Amersham Bio-
sciences) using a 10 mM ammonium acetate solution. The
protein concentration was calculated using results of the
Bradford reagent reaction. 20 μl of the S100A12 solution
was placed in a Slide-A-Lyzer MINI dialysis unit and dia-
lysed overnight against a large volume of solution at the
desired metal-ion concentration. Before analysis the solu-
tion in the MINI-dialysis unit was removed and the pro-
tein solution diluted to the desired concentration using
metal ion solution from the volume used for the dialysis.
NMR experiments
NMR experiments were performed on Avance Bruker spec-
trometer, operating at a 1H frequency of 700 MHz and
equipped with a cryoprobe. All NMR data were collected
at 25°C. Protein samples of S100A12, with concentra-
tions ranging from 0.3–0.5 mM were dissolved in NMR
buffer (10 mM Hepes/NaOH (pH 6.5), 100 mM NaCl,
0.02% (w/v) NaN3.). To prepare Ca2+-S100A12, a solu-
tion of 1 M CaCl2 was titrated into a 0.5 mM [U-15N]
S100A12 solution until the molar ratio of metal:protein
was 6:1. No changes in the NMR spectrum of the protein
were detected at higher molar ratios. To prepare Zn2+Ca2+-
S100A12 a solution of 0.5 M ZnCl2 was titrated into 0.5
mM solution of Ca2+-S100A12 until the molar ratio of
metal:protein was 3:1. No changes in the NMR spectrum
of the protein were detected at higher molar ratios. Gradi-
ent diffusion experiments to obtain translational diffu-
sion coefficient, D, were performed using pulse sequence
described in [58].
This experiment measures the attenuation of the NMR sig-
nal due to the increase in the strength of the gradient field
and can be used to calculate translational diffusion coeffi-
cient, which is for the spherical Brownian particle
inversely proportional to Stokes' radius
KBT being the thermal energy, η the viscosity of the sol-
vent and ra Stokes' radius. In our experiment the diffusion
delay was Δ + 6τ = 1 s; each sine-shaped encoding gradient
lasted δ = 1.3 ms. Translational diffusion coefficient was
calculated by fitting integrated amide signal intensities
using the equation:
where
γ is the proton gyromagnetic ratio, s  the shape of the
encoding and decoding gradient pulses, and Gmax their
peak amplitude.
Structure comparisons and molecular graphics
The structures were superimposed using the program
LSQKAB [59]. Part A of Fig. 10 was generated using
MOLSCRIPT [60] and rendered with Raster3D [61], part B
with CCP4mg [62].
Abbreviations
Zn: (zinc); Ca: (calcium); Cu: (copper); AEBSF: 4-(2-ami-
noethyl)-benzenesulfonyl fluoride; TNS: 6-(p-toluidinyl)
DK T r Ba = /( ) 6ph (5)
SS D / exp{ ( )}, 0
2 6 =− + kt Δ (6)
kg d = sGmax , (7)BMC Biochemistry 2009, 10:11 http://www.biomedcentral.com/1471-2091/10/11
Page 17 of 18
(page number not for citation purposes)
naphthalene-2-sulphonic acid; AFM: (atomic force micro-
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